BioLineRx (BLRX) Tops Q3 EPS by 4c
Get Alerts BLRX Hot Sheet
Join SI Premium – FREE
BioLineRx (NASDAQ: BLRX) reported Q3 EPS of ($0.03), $0.04 better than the analyst estimate of ($0.07).
The Company held $38.9 million in cash, cash equivalents and short-term bank deposits as of September 30, 2016.
For earnings history and earnings-related data on BioLineRx (BLRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Visa (V) stock rises as Q2 earnings, revenue come ahead of estimates
- West Fraser Timber Co. Ltd. (WFG) Tops Q1 EPS by 17c
- Texas Instruments (TXN) jumps on first above-consensus guide in seven years
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!